Serratia corneal ulcers: A retrospective clinical study

Cornea

Volumn 24, Issue 7, 2005, Pages 793-800

  Mah Sadorra, Jeane Haidee ^a   Najjar, Dany M ^a   Rapuano, Christopher J ^a   Laibson, Peter R ^a   Cohen, Elisabeth J ^a,b  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

^b WILLS EYE HOSPITAL   (United States)

Author keywords

Bacterial keratitis; Contact lenses; Penetrating keratoplasty; Serratia marcescens

Indexed keywords

ANTIGLAUCOMA AGENT; BACITRACIN; CEFAZOLIN; CIPROFLOXACIN; CORTICOSTEROID; ERYTHROMYCIN; GENTAMICIN; LEVOFLOXACIN; OFLOXACIN; PIPERACILLIN; POLYMYXIN B; QUINOLINE DERIVED ANTIINFECTIVE AGENT; STEROID; TOBRAMYCIN; VANCOMYCIN;

ADOLESCENT; ADULT; AGED; ANTIBIOTIC SENSITIVITY; ARTICLE; CLINICAL ARTICLE; CLINICAL FEATURE; CONTACT LENS; CORNEA NECROSIS; CORNEA TRANSPLANTATION; CORNEA ULCER; EDEMA; FEMALE; HUMAN; KERATITIS; MALE; MICROBIOLOGICAL EXAMINATION; NONHUMAN; PENETRATING KERATOPLASTY; PRIORITY JOURNAL; RECURRENT DISEASE; RETROSPECTIVE STUDY; SERRATIA MARCESCENS; STEROID THERAPY; SUTURE; TOPICAL TREATMENT;

ADOLESCENT; ADULT; AGED; ANTI-BACTERIAL AGENTS; COMBINED MODALITY THERAPY; CONTACT LENSES; CORNEA; CORNEAL ULCER; EYE INFECTIONS, BACTERIAL; FEMALE; HUMANS; INCIDENCE; KERATOPLASTY, PENETRATING; MALE; MIDDLE AGED; RECURRENCE; RETROSPECTIVE STUDIES; RISK FACTORS; SERRATIA INFECTIONS; SERRATIA MARCESCENS; SURGICAL WOUND INFECTION; TREATMENT OUTCOME; VISUAL ACUITY;

EID: 25844523759     PISSN: 02773740     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.ico.0000159738.06167.88     Document Type: Article

References (32)

1. Equi RA, Green WR. Endogenous Serratia marcescens endophthalmitis with dark hypopyon: a case report and review. Surv Ophthalmol. 2001;46: 259-268.
2. Atlee WE, Burns RP, Oden M. Serratia marcescens keratoconjunctivitis. Am J Ophthalmol. 1970;70:31-33.
3. Lazachek GW, Boyle GL, Schwartz AL, et al. Serratia marcescens, an ocular pathogen: New considerations. Arch Ophthalmol. 1971;86:599-603.
4. Lass JH, Haaf J, Foster CS, et al. Visual outcome in eight cases of Serratia marcescens keratitis. Am J Ophthalmol. 1981;92:384-390.
5. Templeton WC, Eiferman RA, Snyder JW, et al. Serratia keratitis transmitted by contaminated eyedrops. Am J Ophthalmol. 1982;93:723-726.
6. Mayo MS, Schlitzer RL, Ward MA, et al. Association of Pseudomonas and Serratia corneal ulcers with use of contaminated solutions. J Clin Microbiol. 1987;25:1398-1400.
7. Schein OD, Wasson PJ, Boruchoff SA, et al. Microbial keratitis associated with contaminated ocular medications. Am J Ophthalmol. 1988;105:361-365.
8. Duffey RJ. Bilateral Serratia marcescens keratitis after simultaneous bilateral radial keratotomy. Am J Ophthalmol. 1995;119:233-236.
9. Chen KH, Kuang TM, Hsu WM. Serratia marcescens comeal ulcer as a complication of orthokeratology. Am J Ophthalmol. 2001;132:257-258.
10. Leahey AB, Avery RL, Gottsch JD, et al. Suture abscess after penetrating keratoplasty. Cornea. 1993;12:489-492.
11. Holden BA, La Hood D, Grant T, et al. Gram-negative bacteria can induce contact lens related acute red eye (CLARE) responses. CLAO J. 1996;22: 47-52.
12. Hwang YS, Chen YF, Lai CC, et al. Infectious scleritis after use of immunomodulators. Arch Ophthalmol. 2002;120:1093-1094.
13. Bigger JF, Meltzer G, Mandell A, et al. Serratia marcescens endophthalmitis. Am J Ophthalmol. 1971;72:1102-1105.
14. Salceda SR, Lapuz J, Vizconde R. Serratia marcescens endophthalmitis. Arch Ophthalmol. 1973;89:163-166.
15. Al Hazaa SAF, Tabbara KF, Gammon JA. Pink hypopyon: a sign of Serratia marcescens endophthalmitis. Br J Ophthalmol. 1992;76:764-765.
16. Cheng KH, Leung SL, Hoekman WH, et al. Incidence of contact-lens- associated microbial keratitis and its related morbidity. Lancet. 1999;354: 181-185.
17. Alexandrakis G, Alfonso EC, Miller D. Shifting trends in bacterial keratitis in South Florida and emerging resistance to fluoroquinolones. Ophthalmology. 2000;107:1497-1502.
18. Schaefer F, Bruttin O, Zografos L, et al. Bacterial keratitis: a prospective clinical and microbiological study. Br J Ophthalmol. 2001;85:842-847.
19. Bourcier T, Thomas F, Borderie V, et al. Bacterial keratitis: predisposing factors, clinical and microbiological review of 300 cases. Br J Ophthalmol. 2003;87:834-838.
20. Marioneaux SJ, Cohen EJ, Arentsen JJ, et al. Moraxella keratitis. Cornea. 1991;10:21-24.
21. Tuberville AW, Wood TO. Corneal ulcers in corneal transplants. Curr Eye Res. 1981;1:479-485.
22. Harris DJ, Stalling RD, Waring GO, et al. Late bacterial and fungal keratitis after comeal transplantation: Spectrum of pathogens, graft survival, and visual prognosis. Ophthalmology. 1988;95:1450-1457.
23. O'Brien TP. Bacterial keratitis. In: Krachmer JH, Mannis MJ, Holland EJ, eds. Cornea: Cornea and External Disease: Clinical Diagnosis and Management. St. Louis, MO: Mosby; 1997.
24. Hume EBH, Willcox MDP. Adhesion and growth of Serratia marcescens on artificial closed eye tears soaked hydrogel contact lenses. Aust N Z J Ophthalmol. 1997;25(Suppl 1):S39-S41.
25. Wilson LA, Sawant AD, Ahearn DG. Comparative efficacies of soft contact lens disinfectant solutions against microbial films in lens cases. Arch Ophthalmol. 1991;109:1155-1157.
26. Hume EBH, Stapleton F, Willcox MDP. Evasion of cellular ocular defenses by contact lens isolates of Serratia marcescens. Eye Contact Lens. 2003;29:108-112.
27. Kreger AS, Griffin OK. Cornea-damaging proteases of Serratia marcescens. Invest Ophthalmol. 1975;14:190-198.
28. Lyerly D, Gray L, Kreger A. Characterization of rabbit corneal damage produced by serratia keratitis and by a serratia protease. Infect Immun. 1981;33:927-932.
29. Kamata R, Matsumoto K, Okamura R, et al. The serratial 56K protease as a major pathogenic factor in serratial keratitis. Ophthalmology. 1985;92: 1452-1459.
30. Hume EBH, Conerly LL, Moreau JM, et al. Serratia marcescens keratitis: strain-specific corneal pathogenesis in rabbits. Curr Eye Res. 1999;19: 525-532.
31. Schein OD, Hibberd PL, Starck T, et al. Microbial contamination of in-use ocular medications. Arch Ophthalmol. 1992;110:82-85.
32. Geyer O, Bottone EJ, Podos SM, et al. Microbial contamination of medications used to treat glaucoma. Br J Ophthalmol. 1995;79:376-379.